Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-03-11 | Mr. Ian Michael EstepanPresident & COO | -1,10k | 18,68k | Sale to Issuer | 17,03 | 201,98k | -0,54% |
| 2026-03-11 | Mr. Ryan H. WongExec. VP & CFO | -256,00 | 4,36k | Sale to Issuer | 17,03 | 135,06k | -0,19% |
| 2026-03-11 | Dr. Louise R. Rodino-KlapacPresident of Research & Development and Technical Operations | -948,00 | 16,14k | Sale to Issuer | 17,03 | 225,32k | -0,42% |
| 2026-03-12 | Dr. Stephen L. MayoIndependent Director | -7,24k | 123,21k | Verkauf | 17,02 | 1,77k | -80,40% |
| 2026-03-11 | Cristin RothfussInsider | -974,00 | 16,59k | Sale to Issuer | 17,03 | 137,54k | -0,70% |
| 2026-03-09 | Mr. Ryan H. WongExec. VP & CFO | -275,00 | 4,66k | Sale to Issuer | 16,95 | 135,32k | -0,20% |
| 2026-03-09 | Cristin RothfussInsider | -830,00 | 14,07k | Sale to Issuer | 16,95 | 138,52k | -0,60% |
| 2026-03-09 | Dr. Louise R. Rodino-KlapacPresident of Research & Development and Technical Operations | -1,40k | 23,71k | Sale to Issuer | 16,95 | 226,27k | -0,61% |
| 2026-03-09 | Mr. Ian Michael EstepanPresident & COO | -1,62k | 27,44k | Sale to Issuer | 16,95 | 203,08k | -0,79% |
| 2026-03-02 | Cristin RothfussInsider | -408,00 | 6,61k | Sale to Issuer | 16,20 | 139,35k | -0,29% |
| 2026-03-02 | Mr. Ryan H. WongExec. VP & CFO | -450,00 | 7,29k | Sale to Issuer | 16,20 | 135,60k | -0,33% |
| 2026-03-01 | Mr. Ian Michael EstepanPresident & COO | 3,95k | 0,00 | Derivative Exercise and Retained Stock | - | 204,70k | 1,97% |
| 2026-03-01 | Mr. Ian Michael EstepanPresident & COO | -4,18k | 67,65k | Derivative Exercise and Sale | 16,20 | 204,70k | - |
| 2026-03-01 | Dr. Louise R. Rodino-KlapacPresident of Research & Development and Technical Operations | 3,64k | 0,00 | Derivative Exercise and Retained Stock | - | 227,67k | 1,62% |
| 2026-03-01 | Dr. Louise R. Rodino-KlapacPresident of Research & Development and Technical Operations | -4,49k | 72,66k | Derivative Exercise and Sale | 16,20 | 227,67k | - |
| 2026-02-26 | Mr. Ian Michael EstepanPresident & COO | 7,45k | 102,14k | Derivative Exercise and Retained Stock | 13,71 | 200,75k | 3,85% |
| 2026-01-29 | Dr. Claude NicaiseIndependent Non-Employee Director | -6,78k | 50,99k | Derivative Exercise and Sale | 13,71 - 21,23 | 29,15k | - |
| 2026-01-29 | Dr. Claude NicaiseIndependent Non-Employee Director | 3,72k | 51,00k | Derivative Exercise and Retained Stock | 13,71 | 29,15k | 14,63% |
| 2026-01-27 | Dr. M. Kathleen Behrens WilseyIndependent Chairwoman | 4,01k | 54,92k | Derivative Exercise and Retained Stock | 13,71 | 205,10k | 1,99% |
| 2026-01-27 | Dr. M. Kathleen Behrens WilseyIndependent Chairwoman | -6,49k | 54,94k | Derivative Exercise and Sale | 13,71 - 22,17 | 205,10k | - |
| 2025-12-16 | Mr. Ian Michael EstepanPresident & COO | -13,19k | 294,20k | Verkauf | 22,31 | 193,30k | -6,39% |
| 2025-12-01 | Mr. Ryan H. WongExec. VP & CFO | -158,00 | 3,31k | Sale to Issuer | 20,96 | 136,05k | -0,12% |
| 2025-11-28 | Cristin RothfussInsider | -229,00 | 4,84k | Sale to Issuer | 21,12 | 139,76k | -0,16% |
| 2025-11-17 | Dr. Louise R. Rodino-KlapacPresident of Research & Development and Technical Operations | -4,58k | 84,40k | Sale to Issuer | 18,42 | 224,03k | -2,00% |
| 2025-07-31 | Mr. Ryan H. WongExec. VP & CFO | -327,00 | 5,37k | Sale to Issuer | 16,42 | 17,33k | -1,85% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
